MedTrace Logo

Clinical Performance of Glass-hybrid in the Treatment of Class III Restorations

NCT05843734 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2023-05-06

No results posted yet for this study

Summary

This is a double blinded, split mouth, randomized clinical study that evaluated the performance of a glass hybrid restorative material in class III lesions. The lesions will be restored with glass hybrid restorative (Equia Forte) or anterior composite resin (G-aenial Anterior). Restorations will be evaluated after 24 months according to FDI criteria and the data will be analyzed.

Conditions

  • Class III Dental Caries

Interventions

PROCEDURE

Equia forte HT

Restoration of anterior class III caries lesions

Sponsors & Collaborators

  • Hacettepe University

    lead OTHER

Principal Investigators

  • UZAY Koç VURAL, PhD.DDS · Hacettepe

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-01-01
Primary Completion
2024-02-29
Completion
2025-12-31

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05843734 on ClinicalTrials.gov